BiotechTube
Home/Aion Medicines/Brian Kearney, PharmD
BK

Brian Kearney, PharmD

Chief Scientific and Development Officer

Aion Medicines

Therapeutic Areas

Metabolic DiseaseAddiction Medicine

Aion Medicines Pipeline

DrugIndicationPhase
AM-710Type II Diabetes, ObesityPreclinical
AM-510Opioid Use DisorderDiscovery

Leadership Team at Aion Medicines

AY
Alborz Yazdi
Co-Founder and CEO
BE
Benson Edagwa
SVP, Head of Discovery
GE
Gary Elliott
CMC
NM
Nick Morra
CMC
MC
Michael Crowley
CMC
View full Aion Medicines profile